Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has axed its once-monthly double GLP-1/ GIP receptor agonist, finishing (PDF) developm...

Daiichi pays Merck $170M to create lung cancer cells T-cell engager deal

.Merck &amp Co. has actually swiftly gotten back a few of the prices of its own Harp on Therapies bu...

BioMarin stops preclinical genetics treatment for heart condition

.After BioMarin conducted a spring season tidy of its own pipe in April, the firm has determined tha...

Eisai plants molecular adhesive SEED with $1.5 B biobucks handle

.Large Pharmas remain stuck to the idea of molecular adhesive degraders. The most up to date provide...

Life science credit scores firm introduces with $600M

.A new global lifestyle scientific research debt organization, termed Symbiotic Capital, has actuall...

BMS channels TIGIT, walking away from $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing an additional major wager from the Caforio era, terminating ...

Nuvation standstills BET inhibitor after considering stage 1 data

.After having a look at phase 1 data, Nuvation Biography has chosen to stop focus on its own one-tim...

' Professional instinct' led FDA advisors to support Zevra's unusual ailment med

.Zevra Therapeutics' unusual condition medication seems to become on the path to authorization this ...

Pfizer takes $230M attacked after axing fell short DMD genetics treatment

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) genetics therapy failing has actually blown a $2...

AC Immune sees 'spots' potential in Alzheimer's medicine information

.After much more than 20 years of service neurodegenerative health conditions, Swiss biotech air con...